We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$45.3M
AUM Growth
+$22.2M
Cap. Flow
+$22.8M
Cap. Flow %
50.38%
Top 10 Hldgs %
84.11%
Holding
48
New
20
Increased
3
Reduced
7
Closed
14

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.46M
2
XP icon
XP
XP
+$7.09M
3
VEON icon
VEON
VEON
+$3.48M
4
ECHO
EchoStar
ECHO
+$2.64M
5
ATAI icon
AtaiBeckley Inc
ATAI
+$2.1M

Top Sells

Rank Stock Value
1
STNE icon
StoneCo
STNE
+$6.71M
2
NU icon
Nu Holdings
NU
+$3.39M
3
TSM icon
TSMC
TSM
+$351K
4
NVDA icon
NVIDIA
NVDA
+$312K
5
MCK icon
McKesson
MCK
+$246K

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.44%
2 Financials 26.6%
3 Healthcare 22.23%
4 Communication Services 12.56%
5 Technology 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XP icon
1
XP
XP
$10.1B
$10.7M 23.57%
657,219
+397,671
+153% +$7.09M
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$7.68M 16.95%
+10,290
New +$7.46M
VEON icon
3
VEON
VEON
$4.48B
$3.49M 7.69%
+66,750
New +$3.48M
ATAI icon
4
AtaiBeckley Inc
ATAI
$2.72B
$2.63M 5.81%
+500,000
New +$2.1M
ECHO
5
EchoStar
ECHO
$26.1B
$2.2M 4.84%
+21,635
New +$2.64M
ITUB icon
6
Itaú Unibanco
ITUB
$90.2B
$1.37M 3.02%
+167,800
New +$1.39M
LLY icon
7
Eli Lilly
LLY
$1.02T
$1.32M 2.91%
1,098
-133
-11% -$136K
ABBV icon
8
AbbVie
ABBV
$453B
$722K 1.59%
2,871
-200
-7% -$43K
INCY icon
9
Incyte
INCY
$25.9B
$637K 1.41%
5,620
– –
JNJ icon
10
Johnson & Johnson
JNJ
$664B
$601K 1.33%
2,368
+236
+11% +$55K
UNH icon
11
UnitedHealth
UNH
$357B
$517K 1.14%
+1,243
New +$461K
ONC
12
BeOne Medicines Ltd
ONC
$40.5B
$488K 1.08%
1,711
– –
MRK icon
13
Merck
MRK
$371B
$433K 0.96%
+3,372
New +$395K
STM icon
14
STMicroelectronics
STM
$46.6B
$401K 0.88%
+5,348
New +$322K
NVDA icon
15
PUT
NVIDIA
NVDA
$5.57T
$374K 0.82%
+3,000
New +$617K
VRTX icon
16
Vertex Pharmaceuticals
VRTX
$139B
$360K 0.79%
725
+188
+35% +$83.3K
BMY icon
17
Bristol-Myers Squibb
BMY
$136B
$355K 0.78%
6,154
-7
-0.1% -$402
RVMD icon
18
Revolution Medicines
RVMD
$44.8B
$333K 0.73%
+1,778
New +$260K
GILD icon
19
Gilead Sciences
GILD
$187B
$270K 0.6%
2,138
-193
-8% -$25.4K
TMO icon
20
Thermo Fisher Scientific
TMO
$226B
$268K 0.59%
534
-170
-24% -$81.6K
ABT icon
21
Abbott
ABT
$189B
$261K 0.58%
2,874
-220
-7% -$20.1K
MDGL icon
22
Madrigal Pharmaceuticals
MDGL
$12.5B
$232K 0.51%
433
– –
ISRG icon
23
Intuitive Surgical
ISRG
$129B
$225K 0.5%
566
-184
-25% -$80.4K
SYK icon
24
Stryker
SYK
$116B
$218K 0.48%
+691
New +$218K
ACAD icon
25
Acadia Pharmaceuticals
ACAD
$4.81B
$205K 0.45%
+8,110
New +$178K
1
2

Similar funds

BIC
B&I Capital Zurich, Switzerland $45.3M AUM 17.6% 1-Year Est. Return
CUIC
China-UAE Investment Cooperation George Town $45.2M AUM
SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
GP
Gallo Partners Bloomfield, New Jersey $45.1M AUM 107.95% 1-Year Est. Return
FRGX
First Reserve GP XIII Stamford, Connecticut $45.9M AUM 25.65% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $46M AUM 10.1% 1-Year Est. Return
CAM
Capital Asset Management Denver, Colorado $44.4M AUM
CWM
Consultiva Wealth Management San Juan, Puerto Rico $44.4M AUM 37.25% 1-Year Est. Return

JGP Global Gestao de Recursos's Q2 2026 Portfolio in Review

As of Q2 2026, JGP Global Gestao de Recursos held 48 positions worth $45.3M, up 96% from $23.2M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

JGP Global Gestao de Recursos deployed $22.8M of net new capital in Q2 2026, opening 20 new positions and adding to 3 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 10,290 shares worth $7.68M.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 3.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $136K trimmed.

  • JGP Global Gestao de Recursos's largest Q2 2026 buy was State Street SPDR S&P 500 ETF Trust: 10,290 shares worth $7.68M.
  • JGP Global Gestao de Recursos added most to XP in Q2 2026, an estimated $7.09M increase.
  • JGP Global Gestao de Recursos's biggest Q2 2026 reduction was Eli Lilly, cutting an estimated $136K.
  • JGP Global Gestao de Recursos fully exited StoneCo in Q2 2026, selling an estimated $6.71M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 84% of its $45.3M portfolio in Q2 2026.
  • JGP Global Gestao de Recursos opened 20 new positions and closed 14 in Q2 2026.
  • JGP Global Gestao de Recursos's portfolio value rose 96% quarter-over-quarter to $45.3M.

Based on JGP Global Gestao de Recursos's 13F filing for Q2 2026, filed 20 Jul 2026.